Literature DB >> 8158659

"Dose"-dependency and temporal characteristics of protection by ischaemic preconditioning against ischaemia-induced arrhythmias in rat hearts.

C S Lawson1, D J Coltart, D J Hearse.   

Abstract

Brief episodes of ischaemia and reperfusion (preconditioning) can increase the resistance of the myocardium to ischaemic injury. We investigated the temporal characteristics of anti-arrhythmic protection by preconditioning. Rat hearts underwent regional ischaemia (+/- reperfusion) of the left coronary territory. Control isolated blood-perfused hearts underwent 40 min ischaemia; in the preconditioned groups this was preceded by one, two or three cycles of 5 min ischaemia and 5 min reperfusion. Control anaesthetized rats underwent 60 min ischaemia; this was preceded by three cycles of 3 min ischaemia and 3 min reperfusion in the preconditioned group. Preconditioning led to: (i) the abolition of ventricular fibrillation in both in vivo and in vitro preparations; (ii) a reduced incidence of ventricular tachycardia (from 100% to 8% in vitro and 100% to 25% in vivo); and (iii) a reduced incidence of ventricular premature beats (from 246 +/- 36 to 8 +/- 5 in vitro and 85 +/- 21 to 24 +/- 13 in vivo). In isolated hearts protection was proportional to the number of preconditioning cycles. Although preconditioning caused a dramatic reduction in the severity of arrhythmias it did not result in any significant alteration in their temporal profiles. We conclude that protection by preconditioning against ischaemia-induced arrhythmias is "dose"-dependent in rat hearts in vitro and results in an absolute reduction in the severity of ischaemia-induced arrhythmias rather than an alteration in their time-course, both in vivo and in vitro.

Entities:  

Mesh:

Year:  1993        PMID: 8158659     DOI: 10.1006/jmcc.1993.1156

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  13 in total

1.  Effects of HNS-32, a novel antiarrhythmic drug, on ventricular arrhythmias induced by coronary artery occlusion and reperfusion in anesthetized rats.

Authors:  M Saitoh; N N Aye; S Komori; T Nakazawa; K Hashimoto
Journal:  Mol Cell Biochem       Date:  2000-02       Impact factor: 3.396

Review 2.  Preconditioning-induced protection against post-ischemic contractile dysfunction: inhibitory effect of tissue washout.

Authors:  A C Cave; C S Apstein
Journal:  Basic Res Cardiol       Date:  1996 Jan-Feb       Impact factor: 17.165

3.  Effect of repetitive episodes of exercise induced myocardial ischaemia on left ventricular function in patients with chronic stable angina: evidence for cumulative stunning or ischaemic preconditioning?

Authors:  C A Rinaldi; N D Masani; A Z Linka; R J Hall
Journal:  Heart       Date:  1999-04       Impact factor: 5.994

4.  Preconditioning: a balanced perspective.

Authors:  K Przyklenk; R A Kloner
Journal:  Br Heart J       Date:  1995-12

Review 5.  Ischaemic preconditioning of myocardium: a new paradigm for clinical cardioprotection?

Authors:  G F Baxter; D M Yellon
Journal:  Br J Clin Pharmacol       Date:  1994-11       Impact factor: 4.335

6.  Effects and interaction, of cariporide and preconditioning on cardiac arrhythmias and infarction in rat in vivo.

Authors:  N N Aye; S Komori; K Hashimoto
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

7.  The isolated blood-perfused rat heart: an inappropriate model for the study of ischaemia- and infarction-related ventricular fibrillation.

Authors:  Hugh Clements-Jewery; David J Hearse; Michael J Curtis
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

Review 8.  Preconditioning the human myocardium: recent advances and aspirations for the development of a new means of cardioprotection in clinical practice.

Authors:  D P Jenkins; S E Steare; D M Yellon
Journal:  Cardiovasc Drugs Ther       Date:  1995-12       Impact factor: 3.727

9.  Preconditioning stimuli do not benefit the myocardium of hypoxia-tolerant rainbow trout (Oncorhynchus mykiss).

Authors:  Johannes Overgaard; Jonathan A W Stecyk; Hans Gesser; Tobias Wang; A Kurt Gamperl; Anthony P Farrell
Journal:  J Comp Physiol B       Date:  2004-03-04       Impact factor: 2.200

10.  Myocardial protection by ischemic preconditioning: the influence of the composition of myocardial phospholipids.

Authors:  S al Makdessi; M Brändle; M Ehrt; H Sweidan; R Jacob
Journal:  Mol Cell Biochem       Date:  1995-04-12       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.